Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:NYAG, SEC Target Inviva Affiliate for Market Timing Not Rated 0.0 Email Routing List Email & Route  Print Print
Tuesday, May 4, 2004

NYAG, SEC Target Inviva Affiliate for Market Timing

News summary by MFWire's editors

A former unit of Conseco is reportedly in hot water over improper trading inside its variable annuities. Both the SEC and the New York State Attorney General's Office (NYAG) are investigating activity in accounts offered by Jefferson National Life Insurance Company. The insurer revealed the probes in an SEC filing Friday.

The insurer also revealed that the SEC's Northeast Regional Office sent it a Wells notice on March 12 of this year. The SEC typically notifies targets of potential action through Wells notices and provides them with an opportunity to respond.

The SEC staff said in the Wells notice that they may recommend a civil injunctive action against Jefferson National based on alleged market-timing in variable annuity contracts. The insurer also disclosed that Eliot Spitzer told it his office could bring similar charges under the New York Martin Act.

Jefferson National is an affiliate of Inviva Inc. The privately-owned company purchased the insurer from Conseco in October 2002. The SEC and NYAG notified Conseco in January that they are considering enforcement actions based on market timing in variable annuity policies. Conseco has claimed that insurer did not violate federal or state laws before it was sold to Inviva.  

Edited by: Sean Hanna, Editor in Chief


Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2025: Q1
2024: Q4Q3Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. MFDF Spotlight - Onboarding AI: Do's and Don'ts in the Boardroom, January 14
  2. MMI webinar - Enhancing the Advisor Experience, January 16
  3. MFDF webinar - AI and Fund Compliance, January 21
  4. MFDF In Focus - In Focus: Small Boards' Use of Skills Matrices, January 22
  5. IDC webinar - SEC Enforcement Trends: What Fund Directors Should Know, January 23
  6. ICI webinar - Legal and Compliance Career Opportunities in the Asset Management Industry, January 24
  7. FSI OneVoice 2025, Jan 27-29
  8. MFDF 2025 Directors' Institute, Jan 27-29
  9. Nicsa webinar - An Intro to Irish and Luxembourg Investment Platforms for US Asset Managers, January 29
  10. WE South - Dallas | Texas Stock Exchange, Politics, & Product Development, January 30
  11. 2025 ICI Innovate, Feb 3-5
  12. Nicsa webinar - AI In Operations: Boosting Productivity for Wealth & Asset Management Firms, February 5
  13. MFDF In Focus: Understanding Distribution - What the Data Can Tell You, February 6
  14. MFDF Director Discussion Series - Open Forum, February 10
  15. MFDF Director Discussion Series - Open Forum, February 11
  16. MMI Darden-in-Residence II, Feb 24-6
  17. 2025 MMI RIA Forum, February 27
  18. IDC Core Responsibilities of Fund Directors, February 27
  19. Citywire Scottsdale CIO Summit 2025, Feb 27-28
  20. Expect Miracles In Manhattan 2025, February 27
  21. T3 Technology Conference 2025, Mar 3-6
  22. IMEA Distribution Intelligence Summit, Mar 4-5
  23. Nicsa 2025 Strategic Leadership Forum, Mar 5-7
  24. Citywire Pro Buyer New York Due Diligence Retreat 2025, Mar 6-7
  25. MFDF 2025 Fund Governance & Regulatory Insights Conference, Mar 6-7
  26. MFDF 15(c) White Paper Webinar Series: Part 3 - Gartenberg Factors Analysis and Challenges, March 12




©All rights reserved to InvestmentWires, Inc. 1997-2025
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use